CALASPARGASE PEGOL

CALASPARGASE PEGOL was reported 804 times

CALASPARGASE PEGOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DRUG METABOLITE LEVEL 1 0.5000
1 CHEMOTHERAPEUTIC DRUG LEVEL BELOW THERAPEUTIC 2 0.1333
2 PICORNAVIRUS INFECTION 5 0.1163
3 PANCREATIC PSEUDOCYST HAEMORRHAGE 1 0.1000
4 STRUCTURAL BRAIN DISORDER 1 0.1000
5 SEPTIC COAGULOPATHY 1 0.0714
6 PANCREATIC PSEUDOANEURYSM 1 0.0526
7 HEPATOSPLENIC ABSCESS 1 0.0476
8 ENZYME ACTIVITY DECREASED 1 0.0455
9 ENZYME ACTIVITY INCREASED 1 0.0312
10 CONGENITAL APLASIA 8 0.0257
11 PSEUDOHYPONATRAEMIA 3 0.0219
12 ENZYME INHIBITION 2 0.0208
13 BACTEROIDES BACTERAEMIA 1 0.0167
14 CSF WHITE BLOOD CELL COUNT POSITIVE 1 0.0135
15 FUNGAL ABSCESS CENTRAL NERVOUS SYSTEM 1 0.0132
16 PANCREATITIS HAEMORRHAGIC 5 0.0108
17 SEPTIC PULMONARY EMBOLISM 2 0.0103
18 VITH NERVE DISORDER 1 0.0099
19 HYPERTRIGLYCERIDAEMIA 56 0.0096
20 BACILLUS BACTERAEMIA 1 0.0092
21 HERPES SIMPLEX VIRAEMIA 1 0.0080
22 MEDICAL DEVICE SITE ERYTHEMA 1 0.0078
23 ENZYME LEVEL DECREASED 1 0.0076
24 ANTITHROMBIN III DECREASED 2 0.0073
25 PERINEAL ULCERATION 1 0.0071
26 PINEAL GLAND CYST 1 0.0071
27 HYPERINSULINAEMIA 2 0.0065
28 PANCREATITIS NECROTISING 15 0.0065
29 BLOOD INSULIN DECREASED 1 0.0065
30 PANCREATIC PSEUDOCYST 5 0.0064
31 PSEUDOCYST 2 0.0062
32 TREATMENT DELAYED 10 0.0058
33 ABSCESS FUNGAL 1 0.0057
34 INTRACARDIAC MASS 1 0.0056
35 ANISOCORIA 2 0.0053
36 HAEMOFILTRATION 1 0.0053
37 STENT MALFUNCTION 1 0.0051
38 SUPERIOR SAGITTAL SINUS THROMBOSIS 4 0.0050
39 NEUTRALISING ANTIBODIES POSITIVE 2 0.0048
40 OCULAR TOXICITY 5 0.0045
41 DISSEMINATED ASPERGILLOSIS 2 0.0042
42 ANORECTAL INFECTION 1 0.0040
43 BINOCULAR EYE MOVEMENT DISORDER 1 0.0035
44 INFUSION RELATED HYPERSENSITIVITY REACTION 2 0.0033
45 VENOOCCLUSIVE LIVER DISEASE 16 0.0032
46 ABDOMINAL COMPARTMENT SYNDROME 2 0.0031
47 CANDIDA PNEUMONIA 1 0.0031
48 KLEBSIELLA TEST POSITIVE 2 0.0031
49 GIARDIASIS 1 0.0029
50 CIRCUMORAL OEDEMA 1 0.0029
51 STRABISMUS 8 0.0027
52 BILE DUCT STENT INSERTION 1 0.0026
53 ADMINISTRATION SITE REACTION 1 0.0026
54 PSEUDOMONAS TEST POSITIVE 2 0.0024
55 SUPERFICIAL VEIN THROMBOSIS 2 0.0024
56 CEREBRAL VENOUS SINUS THROMBOSIS 2 0.0024
57 ENTEROVIRUS INFECTION 2 0.0023
58 REFUSAL OF TREATMENT BY RELATIVE 1 0.0022
59 THERAPEUTIC PRODUCT EFFECT PROLONGED 1 0.0022
60 BONE INFARCTION 1 0.0022
61 DRUG SPECIFIC ANTIBODY 3 0.0022
62 CRANIAL NERVE PARALYSIS 1 0.0021
63 HYPOALBUMINAEMIA 16 0.0021
64 MESENTERIC VEIN THROMBOSIS 2 0.0020
65 SPLENIC VEIN THROMBOSIS 1 0.0020
66 CACHEXIA 10 0.0019
67 ATRIAL THROMBOSIS 4 0.0019
68 POSTURING 1 0.0019
69 TRANSVERSE SINUS THROMBOSIS 1 0.0019
70 PULMONARY MUCORMYCOSIS 1 0.0019
71 ASTERIXIS 2 0.0019
72 ANAPHYLACTIC REACTION 103 0.0019
73 DRUG SPECIFIC ANTIBODY PRESENT 12 0.0018
74 TYPE III IMMUNE COMPLEX MEDIATED REACTION 1 0.0018
75 MEDICAL DEVICE SITE PAIN 1 0.0018
76 PAROTITIS 2 0.0017
77 RESPIRATORY SYNCYTIAL VIRUS INFECTION 15 0.0017
78 GRUNTING 1 0.0017
79 DRUG LEVEL BELOW THERAPEUTIC 9 0.0016
80 PHARYNGEAL HAEMORRHAGE 2 0.0016
81 SERUM SICKNESS-LIKE REACTION 1 0.0016
82 BACILLUS INFECTION 1 0.0016
83 SOFT TISSUE NECROSIS 1 0.0015
84 HYPERAMMONAEMIA 7 0.0014
85 VASOGENIC CEREBRAL OEDEMA 1 0.0014
86 PANCREATITIS 71 0.0013
87 LABORATORY TEST INTERFERENCE 1 0.0013
88 FUNGAEMIA 2 0.0013
89 HEPATITIS VIRAL 1 0.0012
90 VASOPLEGIA SYNDROME 2 0.0012
91 ELECTROLYTE IMBALANCE 14 0.0012
92 FUNGAL SEPSIS 1 0.0012
93 SYSTEMIC CANDIDA 3 0.0012
94 PSEUDOMONAL BACTERAEMIA 1 0.0012
95 POLYNEUROPATHY 14 0.0012
96 AXONAL NEUROPATHY 1 0.0011
97 SPLENIC INFARCTION 2 0.0011
98 HYPERSENSITIVITY 211 0.0011
99 HYPERLEUKOCYTOSIS 1 0.0011
100 CEREBRAL VENOUS THROMBOSIS 2 0.0011
101 COAGULOPATHY 18 0.0011
102 PSYCHOGENIC SEIZURE 1 0.0011
103 FEBRILE NEUTROPENIA 71 0.0011
104 CEREBRAL THROMBOSIS 3 0.0011
105 ONCOLOGIC COMPLICATION 1 0.0010
106 GASTROINTESTINAL NECROSIS 3 0.0010
107 INFUSION RELATED REACTION 67 0.0010
108 HYPOFIBRINOGENAEMIA 1 0.0010
109 BLADDER DYSFUNCTION 1 0.0010
110 EAR SWELLING 2 0.0009
111 GALLBLADDER ENLARGEMENT 1 0.0009
112 HEPATOTOXICITY 20 0.0009
113 EYELID PTOSIS 9 0.0009
114 VITH NERVE PARALYSIS 1 0.0009
115 ESCHERICHIA BACTERAEMIA 2 0.0008
116 ESCHERICHIA TEST POSITIVE 1 0.0008
117 HYPOVOLAEMIC SHOCK 4 0.0008
118 CIRCULATORY COLLAPSE 14 0.0008
119 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
120 TACHYARRHYTHMIA 2 0.0008
121 VENOOCCLUSIVE DISEASE 2 0.0008
122 AMMONIA INCREASED 4 0.0008
123 HEPATOSPLENOMEGALY 2 0.0008
124 OBSTRUCTION GASTRIC 1 0.0008
125 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 2 0.0008
126 MUCORMYCOSIS 2 0.0008
127 TONIC CLONIC MOVEMENTS 1 0.0008
128 PNEUMONIA FUNGAL 3 0.0008
129 PANCREATITIS ACUTE 17 0.0008
130 SUBDURAL HAEMORRHAGE 2 0.0007
131 EYE MOVEMENT DISORDER 5 0.0007
132 PULSELESS ELECTRICAL ACTIVITY 3 0.0007
133 NOROVIRUS INFECTION 1 0.0007
134 RENAL INFARCT 1 0.0007
135 STRIDOR 2 0.0007
136 SUPERINFECTION 1 0.0007
137 BLOOD PRESSURE IMMEASURABLE 1 0.0007
138 CLOSTRIDIUM DIFFICILE INFECTION 14 0.0006
139 URINE KETONE BODY PRESENT 1 0.0006
140 HYPERGLYCAEMIA 23 0.0006
141 ASPERGILLUS INFECTION 4 0.0006
142 HYPERVOLAEMIA 3 0.0006
143 ANTIBODY TEST POSITIVE 1 0.0006
144 DRUG LEVEL DECREASED 6 0.0006
145 SLEEP TALKING 1 0.0006
146 HYPERBILIRUBINAEMIA 6 0.0006
147 HYPERTRANSAMINASAEMIA 4 0.0006
148 PANCREATIC FAILURE 1 0.0006
149 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
150 PNEUMONIA KLEBSIELLA 1 0.0005
151 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
152 LIPASE INCREASED 4 0.0005
153 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
154 RHINOVIRUS INFECTION 2 0.0005
155 CORONARY ARTERY THROMBOSIS 1 0.0005
156 NEUTROPENIC COLITIS 1 0.0005
157 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
158 EXOPHTHALMOS 1 0.0005
159 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
160 PANCYTOPENIA 25 0.0004
161 MALNUTRITION 5 0.0004
162 DISTRIBUTIVE SHOCK 1 0.0004
163 ACUTE HEPATIC FAILURE 6 0.0004
164 BILIRUBIN CONJUGATED INCREASED 1 0.0004
165 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
166 DRUG LEVEL INCREASED 7 0.0004
167 BACTERAEMIA 5 0.0004
168 PULSE ABSENT 2 0.0004
169 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
170 PULSE ABNORMAL 1 0.0004
171 INTRAVENTRICULAR HAEMORRHAGE 1 0.0004
172 CATHETER SITE HAEMORRHAGE 1 0.0004
173 NEUROTOXICITY 7 0.0004
174 ABDOMINAL INFECTION 1 0.0004
175 SEPTIC SHOCK 17 0.0004
176 PHYSICAL DECONDITIONING 1 0.0004
177 MULTIPLE ORGAN DYSFUNCTION SYNDROME 11 0.0004
178 PERIORBITAL OEDEMA 2 0.0004
179 MUCOSAL INFLAMMATION 10 0.0004
180 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
181 PROCTITIS 1 0.0004
182 ENTEROCOLITIS 2 0.0003
183 BLOOD CULTURE POSITIVE 1 0.0003
184 EMERGENCY CARE 1 0.0003
185 ADRENAL INSUFFICIENCY 4 0.0003
186 GENERALISED OEDEMA 4 0.0003
187 TACHYCARDIA 28 0.0003
188 PORTAL VEIN THROMBOSIS 1 0.0003
189 LIVER ABSCESS 1 0.0003
190 BACTERIAL SEPSIS 1 0.0003
191 HYPOVENTILATION 1 0.0003
192 THERAPY CHANGE 3 0.0003
193 CORONAVIRUS INFECTION 2 0.0003
194 RESPIRATORY DISTRESS 8 0.0003
195 DROOLING 2 0.0003
196 EAR PRURITUS 1 0.0003
197 TYPE I HYPERSENSITIVITY 1 0.0003
198 EMBOLIC STROKE 1 0.0003
199 RETCHING 6 0.0003
200 FOOD INTOLERANCE 1 0.0003
201 AMYLASE INCREASED 1 0.0003
202 HEPATIC STEATOSIS 5 0.0003
203 THERAPY NON-RESPONDER 12 0.0003
204 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
205 PULMONARY HAEMORRHAGE 2 0.0003
206 POLYDIPSIA 1 0.0003
207 OESOPHAGEAL CANDIDIASIS 1 0.0003
208 CYSTITIS HAEMORRHAGIC 1 0.0002
209 COLITIS 9 0.0002
210 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
211 HYPOPHAGIA 6 0.0002
212 MYOPATHY 2 0.0002
213 TUMOUR LYSIS SYNDROME 2 0.0002
214 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
215 PAPILLOEDEMA 1 0.0002
216 RESPIRATORY FAILURE 16 0.0002
217 GASTROINTESTINAL HAEMORRHAGE 18 0.0002
218 HEPATIC ENCEPHALOPATHY 2 0.0002
219 ATELECTASIS 2 0.0002
220 ENTEROCOCCAL INFECTION 1 0.0002
221 HEPATOMEGALY 2 0.0002
222 ANGIOEDEMA 9 0.0002
223 ORGANISING PNEUMONIA 1 0.0002
224 HYPOTONIA 2 0.0002
225 DRUG TOLERANCE 1 0.0002
226 SUBARACHNOID HAEMORRHAGE 2 0.0002
227 CEREBRAL HAEMORRHAGE 7 0.0002
228 ENDOCARDITIS 1 0.0002
229 UNRESPONSIVE TO STIMULI 5 0.0002
230 NEUTROPENIA 26 0.0002
231 CYANOSIS 3 0.0002
232 BLOOD LACTIC ACID INCREASED 1 0.0002
233 POLYARTHRITIS 1 0.0002
234 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
235 SEPSIS 21 0.0002
236 HYPOGLYCAEMIA 9 0.0002
237 BLOOD BILIRUBIN INCREASED 5 0.0002
238 HYDROCEPHALUS 1 0.0002
239 INTESTINAL ISCHAEMIA 1 0.0002
240 LIP SWELLING 6 0.0002
241 FUNGAL INFECTION 6 0.0002
242 NECROSIS 1 0.0002
243 INTRACRANIAL PRESSURE INCREASED 1 0.0002
244 HEART RATE ABNORMAL 1 0.0002
245 CANDIDA INFECTION 3 0.0002
246 PERIORBITAL SWELLING 1 0.0002
247 HYPOVOLAEMIA 1 0.0002
248 HYPERLIPIDAEMIA 2 0.0002
249 PROTHROMBIN TIME PROLONGED 1 0.0002
250 HEPATITIS CHOLESTATIC 1 0.0002
251 GANGRENE 1 0.0002
252 PLATELET COUNT ABNORMAL 1 0.0002
253 CEREBRAL INFARCTION 4 0.0002
254 OLIGURIA 1 0.0002
255 ENTERITIS 1 0.0002
256 HERPES SIMPLEX 1 0.0002
257 SKIN MASS 1 0.0001
258 MENINGITIS 1 0.0001
259 CYTOKINE RELEASE SYNDROME 3 0.0001
260 TACHYPNOEA 2 0.0001
261 CARDIAC ARREST 12 0.0001
262 RESPIRATION ABNORMAL 1 0.0001
263 ENCEPHALITIS 1 0.0001
264 THROMBOCYTOPENIA 16 0.0001
265 HYPOXIA 5 0.0001
266 LIVER FUNCTION TEST INCREASED 3 0.0001
267 FLUSHING 14 0.0001
268 ASCITES 4 0.0001
269 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
270 HAEMORRHAGE INTRACRANIAL 2 0.0001
271 HEPATIC FAILURE 4 0.0001
272 ACIDOSIS 1 0.0001
273 SHOCK 3 0.0001
274 PROCEDURAL COMPLICATION 1 0.0001
275 HAEMORRHAGIC STROKE 1 0.0001
276 RENAL FAILURE 17 0.0001
277 HAEMORRHAGE 13 0.0001
278 HYPONATRAEMIA 7 0.0001
279 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
280 HAEMODIALYSIS 1 0.0001
281 FACIAL PARALYSIS 1 0.0001
282 PSEUDOMONAS INFECTION 1 0.0001
283 GROIN PAIN 1 0.0001
284 IMMUNOSUPPRESSION 1 0.0001
285 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
286 HEAVY MENSTRUAL BLEEDING 1 0.0001
287 ACUTE KIDNEY INJURY 17 0.0001
288 PNEUMONIA BACTERIAL 1 0.0001
289 URTICARIA 18 0.0001
290 BACTERIAL INFECTION 2 0.0001
291 NEPHROPATHY 1 0.0001
292 OXYGEN SATURATION DECREASED 6 0.0001
293 FLANK PAIN 1 0.0001
294 LEUKAEMIA 1 0.0001
295 NEUROPATHY PERIPHERAL 10 0.0001
296 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
297 ACUTE RESPIRATORY FAILURE 2 0.0001
298 CHOKING 2 0.0001
299 PSYCHOTIC DISORDER 3 0.0001
300 EAR DISCOMFORT 1 0.0001
301 PERITONITIS 2 0.0001
302 PETECHIAE 1 0.0001
303 DRUG-INDUCED LIVER INJURY 3 0.0001
304 SUDDEN DEATH 1 0.0001
305 PRODUCT USE ISSUE 17 0.0001
306 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
307 INFECTION 13 0.0001
308 STATUS EPILEPTICUS 1 0.0001
309 THROMBOSIS 7 0.0001
310 PERICARDIAL EFFUSION 2 0.0001
311 SPLENOMEGALY 1 0.0001
312 COUGH 23 0.0001
313 ILEUS 1 0.0001
314 VOMITING 36 0.0001
315 ORAL CANDIDIASIS 1 0.0001
316 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
317 JAUNDICE 2 0.0001
318 THROAT TIGHTNESS 2 0.0001
319 HEPATIC ENZYME INCREASED 5 0.0001
320 CARDIO-RESPIRATORY ARREST 3 0.0001
321 HEPATOCELLULAR INJURY 1 0.0001
322 DIALYSIS 1 0.0001
323 BRONCHOSPASM 1 0.0001
324 SEIZURE 8 0.0001
325 GASTROENTERITIS 1 0.0001
326 WHEEZING 4 0.0001
327 THROAT IRRITATION 3 0.0001
328 PLEURAL EFFUSION 4 0.0001
329 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
330 HYPOTENSION 13 0.0001
331 MUSCULOSKELETAL CHEST PAIN 1 0.0001
332 THERAPY PARTIAL RESPONDER 1 0.0001
333 OCULAR HYPERAEMIA 3 0.0001
334 METABOLIC ACIDOSIS 2 0.0001
335 LACTIC ACIDOSIS 2 0.0001
336 HEART RATE INCREASED 6 0.0001
337 PHOTOSENSITIVITY REACTION 1 0.0001
338 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
339 VIRAL INFECTION 2 0.0001
340 THERAPY CESSATION 3 0.0001
341 ANAEMIA 11 0.0001
342 ORTHOSTATIC HYPOTENSION 1 0.0001
343 HYPERKALAEMIA 2 0.0001
344 COLD SWEAT 1 0.0001
345 OSTEOMYELITIS 1 0.0001
346 MIDDLE INSOMNIA 1 0.0001
347 BLOOD SODIUM DECREASED 1 0.0001
348 PULMONARY EMBOLISM 5 0.0001
349 ABDOMINAL PAIN 12 0.0001
350 FULL BLOOD COUNT DECREASED 1 0.0000
351 STOMATITIS 3 0.0000
352 FEEDING DISORDER 1 0.0000
353 HALLUCINATION, VISUAL 1 0.0000
354 HYPERHIDROSIS 6 0.0000
355 DEEP VEIN THROMBOSIS 3 0.0000
356 SWELLING FACE 3 0.0000
357 PRODUCT PRESCRIBING ISSUE 1 0.0000
358 LIVER DISORDER 2 0.0000
359 TRANSAMINASES INCREASED 1 0.0000
360 DRUG INTERACTION 7 0.0000
361 PRODUCT AVAILABILITY ISSUE 1 0.0000
362 OROPHARYNGEAL PAIN 4 0.0000
363 THERAPY INTERRUPTED 3 0.0000
364 DIABETIC KETOACIDOSIS 1 0.0000
365 AGITATION 3 0.0000
366 ENCEPHALOPATHY 1 0.0000
367 PRODUCT USE IN UNAPPROVED INDICATION 10 0.0000
368 SYNCOPE 4 0.0000
369 HEPATITIS 1 0.0000
370 CHEST DISCOMFORT 4 0.0000
371 ANAPHYLACTIC SHOCK 1 0.0000
372 PYREXIA 13 0.0000
373 PALLOR 1 0.0000
374 MENTAL STATUS CHANGES 1 0.0000
375 CEREBROVASCULAR ACCIDENT 6 0.0000
376 LIVER FUNCTION TEST ABNORMAL 1 0.0000
377 LABORATORY TEST ABNORMAL 1 0.0000
378 SWOLLEN TONGUE 1 0.0000
379 CYSTITIS 1 0.0000
380 VISUAL ACUITY REDUCED 1 0.0000
381 GAIT INABILITY 1 0.0000
382 TOXICITY TO VARIOUS AGENTS 5 0.0000
383 ERYTHEMA 6 0.0000
384 NAUSEA 23 0.0000
385 RASH MACULAR 1 0.0000
386 PLATELET COUNT DECREASED 3 0.0000
387 MYELOSUPPRESSION 1 0.0000
388 CRYING 1 0.0000
389 HEPATIC FUNCTION ABNORMAL 1 0.0000
390 EPISTAXIS 2 0.0000
391 DYSARTHRIA 1 0.0000
392 BLINDNESS 1 0.0000
393 NEUTROPHIL COUNT DECREASED 1 0.0000
394 RHABDOMYOLYSIS 1 0.0000
395 POLLAKIURIA 1 0.0000
396 DEHYDRATION 3 0.0000
397 NEPHROLITHIASIS 1 0.0000
398 SKIN DISCOLOURATION 1 0.0000
399 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
400 DISEASE RECURRENCE 1 0.0000
401 RASH ERYTHEMATOUS 1 0.0000
402 LEUKOPENIA 1 0.0000
403 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
404 DYSPNOEA 11 0.0000
405 HYPERTENSION 4 0.0000
406 BRADYCARDIA 1 0.0000
407 PRURITUS 7 0.0000
408 MEDICATION ERROR 1 0.0000
409 NECK PAIN 1 0.0000
410 CHILLS 2 0.0000
411 IRRITABILITY 1 0.0000
412 THERAPEUTIC RESPONSE DECREASED 1 0.0000
413 VERTIGO 1 0.0000
414 FEELING HOT 1 0.0000
415 BLOOD PRESSURE DECREASED 1 0.0000
416 CONSTIPATION 3 0.0000
417 DYSGEUSIA 1 0.0000
418 BACK PAIN 3 0.0000
419 INJECTION SITE HAEMORRHAGE 1 0.0000
420 FEELING ABNORMAL 3 0.0000
421 CONFUSIONAL STATE 2 0.0000
422 TREMOR 2 0.0000
423 ABDOMINAL DISCOMFORT 2 0.0000
424 GASTROINTESTINAL DISORDER 1 0.0000
425 ADVERSE DRUG REACTION 1 0.0000
426 ADVERSE EVENT 1 0.0000
427 SWELLING 1 0.0000
428 PAIN IN EXTREMITY 3 0.0000
429 SINUSITIS 1 0.0000
430 HAEMOGLOBIN DECREASED 1 0.0000
431 ABDOMINAL PAIN UPPER 2 0.0000
432 ABDOMINAL DISTENSION 1 0.0000
433 PNEUMONIA 3 0.0000
434 RASH 4 0.0000
435 DECREASED APPETITE 2 0.0000
436 DISEASE PROGRESSION 1 0.0000
437 EMOTIONAL DISTRESS 1 0.0000
438 ANXIETY 2 0.0000
439 OFF LABEL USE 6 0.0000
440 DRUG INEFFECTIVE 9 0.0000
441 HOSPITALISATION 1 0.0000
442 HEADACHE 4 0.0000
443 MYALGIA 1 0.0000
444 URINARY TRACT INFECTION 1 0.0000
445 COVID-19 1 0.0000
446 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
447 CHEST PAIN 1 0.0000
448 BLOOD GLUCOSE INCREASED 1 0.0000
449 SOMNOLENCE 1 0.0000
450 INCORRECT DOSE ADMINISTERED 1 0.0000
451 DIZZINESS 2 0.0000
452 WEIGHT DECREASED 1 0.0000
453 PAIN 2 0.0000
454 DIARRHOEA 2 0.0000
455 FATIGUE 2 0.0000
456 ARTHRALGIA 1 0.0000
457 DEATH 2 0.0000
458 MALAISE 1 0.0000